← Open Payments lookup

MICHAEL JONES: Open Payments

NPI 1407881881 · BRYAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,338 in 118 payments from 23 companies in 2025. Trend: 2023 $2,813 · 2024 $2,740 · 2025 $2,338

Food & beverage: $2,338
CompanyPaymentsAmount
Novo Nordisk Inc30$682
AstraZeneca Pharmaceuticals LP14$306
Lundbeck LLC7$163
Amgen Inc.21$149
Gilead Sciences, Inc.5$121
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$107
Axsome Therapeutics, Inc.4$106
Bayer Healthcare Pharmaceuticals Inc.4$92
Boehringer Ingelheim Pharmaceuticals, Inc.3$89
Exact Sciences Corporation4$68

Products named: Ozempic, Wegovy, REXULTI, Rybelsus, OTEZLA, AIRSUPRA, CAPLYTA, Auvelity.

Industry payments across TX — which companies pay providers there.